Antimicrobial resistance in Neisseria gonorrhoeae in the UK: Surveillance and management

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 10, 2011, Pages 867-876

  Ison, Catherine A ^a   Alexander, Sarah ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

cefixime; cephalosporins; gonorrhea; surveillance; third generation cephalosporins

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; OFLOXACIN; PROBENECID; SPECTINOMYCIN;

ANOGENITAL INFECTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; DRUG MONITORING; DRUG TREATMENT FAILURE; EPIDEMIOLOGICAL DATA; GENITAL TRACT INFECTION; GEOGRAPHIC DISTRIBUTION; GONORRHEA; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; NEISSERIA GONORRHOEAE; NONHUMAN; PHARYNGITIS; PRACTICE GUIDELINE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; CEFIXIME; CEFTRIAXONE; DISEASE MANAGEMENT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GONORRHEA; GREAT BRITAIN; HUMANS; MICROBIAL INTERACTIONS; MICROBIAL SENSITIVITY TESTS; MUTATION; NEISSERIA GONORRHOEAE; PLASMIDS; POPULATION SURVEILLANCE; PUBLIC HEALTH; TREATMENT FAILURE;

EID: 80053654408     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.11.103     Document Type: Article

References (67)

1. Lewis DA. The gonococcus fights back-is this time a knock out? Sex. Transm. Infect. 86(6), 415-421 (2010
2. Unemo M, Golparian D, Syversen G, Vestrheim DF, Moi H. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro. Surveill. 15(47), pii: 19721 (2010
3. Ison C, Hussey J, Sankar K, Evans J, Alexander S. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro. Surveill. 16(14), pii: 19833 (2011
4. Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro. Surveill. 16(6), pii: 19792 (2011). . Important article detailing the first documented treatment failure with ceftriaxone in Europe.
5. Ito M, Deguchi T, Mizutani KS et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob. Agents Chemother. 49(1), 137-143 (2005 (Pubitemid 40065784)
6. Ameyama S, Onodera S, Takahata M et al. Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob. Agents Chemother. 46(12), 3744-3749 (2002 (Pubitemid 35403246)
7. Palmer HM, Young H, Winter A, Dave J. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. J. Antimicrob. Chemother. 62(3), 490-494 (2008). . First report of high-level azithromycin resistance in Neisseria gonorrhoeae. This is important as azithromycin has never been used as a first-line agent for gonorrhea, but resistance may have been selected for via the patient who was being inadvertently treated because they were infected with Chlamydia trachomatis.
8. Chisholm SA, Neal TJ, Alawattegama AB, Birley HD, Howe RA, Ison CA. Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J. Antimicrob. Chemother. 64(2), 353-358 (2009
9. Starnino S, Stefanelli P; Neisseria gonorrhoeae Italian Study Group. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J. Antimicrob. Chemother. 63(6), 1200-1204 (2009
10. Galarza PG, Alcalá B, Salcedo C et al. Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina. Sex. Transm. Infect. 36(12), 787-788 (2009
11. Galarza PG, Abad R, Canigia LF et al. New mutation in 23S rRNA gene associated with high level of azithromycin resistance in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 54(4), 1652-1653 (2010
12. Chisholm SA, Dave J, Ison CA. High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. Antimicrob. Agents Chemother. 54(9), 3812-3816 (2010
13. Forsyth A, Moyes A, Young H. Increased ciprofloxacin resistance in gonococci isolated in Scotland. Lancet 356(9246), 1984-1985 (2000
14. Fenton KA, Ison C, Johnson AP et al. Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002. Lancet 361(9372), 1867-1869 (2003 (Pubitemid 36645183)
15. Cole MJ, Chisholm SA, Hoffmann S, Stary A, Lowndes CM, Ison CA; European Surveillance of Sexually Transmitted Infections Network. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Sex. Transm. Infect. 86(6), 427-432 (2010
16. Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales (GRASP): Report of 2009 data. Health Protection Report Vol. 4, No. 34 (2010
17. Centre for Disease Control and Prevention. Antibiotic-resistant strains of Neisseria gonorrhoeae: Policy guidelines for detection, management and control. MMWR 36(Suppl. 5S), 13S (1987
18. WHO. Guidelines for the Management of Sexually Transmitted Diseases. WHO, Geneva, Switzerland (2003
19. Eastick K. Gonococcal antibiotic surveillance in Scotland (GASS): Prevalence, patterns and trends in 2009. HPS Weekly Report 25 (44), 339-342 (2010
20. Bindayna KM, Ison CA. Sampling methods for monitoring changes in gonococcal populations. Epidemiol. Infect. 103(1), 203-209 (1989 (Pubitemid 19223471)
21. Lewis DA, Ison CA, Forster GE, Goh BT. Tetracycline-resistant Neisseria gonorrhoeae. Characteristics of patients and isolates at a London Genitourinary Medicine Clinic. Sex. Transm. Infect. 23(5), 378-383 (1996 (Pubitemid 26313846)
22. Ivens D, Martin I, Ison C. Neisseria gonorrhoeae in a London sexually transmitted infection clinic not fully sensitive to quinolones: Are isolates imported and how effective is ciprofloxacin as a first-line therapy? Int. J. STD AIDS 11(12), 774-776 (2000 (Pubitemid 32041001)
23. Turner A, Jephcott AE, Haji TC, Gupta PC. Ciprofloxacin resistant Neisseria gonorrhoeae in the UK. Genitourin. Med. 66(1), 43 (1990 (Pubitemid 20095890)
24. Turner A, Gough KR, Jephcott AE, McLean AN. Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline. Genitourin. Med. 71(4), 265-266 (1995
25. Ison CA, Martin IM. Susceptibility of gonococci isolated in London to therapeutic antibiotics: Establishment of a London surveillance programme. London Gonococcal Working Group. Sex. Transm. Infect. 75(2), 107-111 (1999 (Pubitemid 29237000)
26. Ison CA, Martin IM; London Gonococcal Working Group. Gonorrhoea in London: Usefulness of first line therapies. Sex. Transm. Infect. 78(2), 106-109 (2002 (Pubitemid 34548028)
27. Paine TC, Fenton KA, Herring A et al. GRASP: A new national sentinel surveillance initiative for monitoring gonococcal antimicrobial resistance in England and Wales. Sex. Transm. Infect. 77(6), 398-401(2001 (Pubitemid 33086919)
28. Hughes G, Nichols T, Ison CA. Estimating the prevalence of gonococcal resistance to antimicrobials in England and Wales. Sex. Transm. Infect. (2011) (In Press
29. Ison CA, Woodford PJ, Madders H, Claydon E. Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure. Antimicrob. Agents Chemother. 42(11), 2919-2922 (1998 (Pubitemid 28501226)
30. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters (version 1.3). 5 January 2011.
31. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S20. CLSI, PA, USA (2010
32. Andrews JM; BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method (version 8). J. Antimicrob. Chemother. 64(3), 454-489 (2009
33. Bignell CJ. BASHH guideline for gonorrhoea. Sex. Transm. Infect. 80(5), 330-331 (2004). Important resource that details the management guidelines for the treatment of gonorrhea in the UK. (Pubitemid 39389546)
34. Palmer HM, Young H, Martin IM, Ison CA, Spratt BG. The epidemiology of ciprofloxacin resistant isolates of Neisseria gonorrhoeae in Scotland 2002: A comparison of phenotypic and genotypic analysis. Sex. Transm. Infect. 81(5), 403-407 (2005 (Pubitemid 41494355)
35. Palmer HM, Young H. Dramatic increase in a single genotype of TRNG ciprofloxacin-resistant Neisseria gonorrhoeae isolates in men who have sex with men. Int. J. STD AIDS 17(4), 254-256 (2006
36. Hughes G, Simms I, Leong G. Data from UK genitourinary medicine clinics, 2006: A mixed picture. Sex. Transm. Infect. 83(6), 433-435 (2007 (Pubitemid 350043733)
37. Rise in new diagnoses of sexually transmitted infections (UK, 2009). Health Protection Report Vol 4, No. 34 (2010
38. Delpech V, Martin IM, Hughes G et al. Epidemiology and clinical presentation of gonorrhoea in England and Wales: Findings from the Gonococcal Resistance to Antimicrobials Surveillance Programme 2001-2006. Sex. Transm. Infect. 85(5), 317-321 (2009
39. Young H, McElhinney J, Palmer HM; Scottish gonococcal surveillance contributors. Extended surveillance of gonorrhoea in Scotland 2003. Int. J. STD AIDS 17(10), 687-692 (2006 (Pubitemid 44611150)
40. O'Rourke M, Ison CA, Renton AM, Spratt AM. Opa-typing: A high-resolution tool for studying the epidemiology of gonorrhoea. Mol. Microbiol. 17(5), 865-875 (1995
41. Martin IM, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J. Infect. Dis. 189(8), 1497-1505 (2004 (Pubitemid 38552358)
42. Palmer HM, Leeming JP, Turner A. Investigation of an outbreak of ciprofloxacin-resistant Neisseria gonorrhoeae using a simplified opa-typing method. Epidemiol. Infect. 126(2), 219-224 (2001 (Pubitemid 32454733)
43. Palmer HM, Young H, Martin IM, Ison CA, Spratt BG. The epidemiology of ciprofloxacin resistant isolates of Neisseria gonorrhoeae in Scotland 2002: A comparison of phenotypic and genotypic analysis. Sex. Transm. Infect. 81(5), 403-407 (2005 (Pubitemid 41494355)
44. Martin IM, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Changing epidemiologic profile of quinolone-resistant Neisseria gonorrhoeae in London. J. Infect. Dis. 192(7), 1191-1195 (2005 (Pubitemid 41368418)
45. Moodley P, Martin IM, Pillay K, Ison CA, Sturm AW. Molecular epidemiology of recently emergent ciprofloxacin-resistant Neisseria gonorrhoeae in South Africa. Sex. Transm. Infect. 33(6), 357-360 (2006 (Pubitemid 43833022)
46. Monfort L, Caro V, Devaux Z, Delannoy AS, Brisse S, Sednaoui P. First Neisseria gonorrhoeae genotyping analysis in France: Identification of a strain cluster with reduced susceptibility to ceftriaxone. J. Clin. Microbiol. 47(11), 3540-3545 (2009
47. Starnino S, Suligoi B, Regine V et al. Phenotypic and genotypic characterization of Neisseria gonorrhoeae in parts of Italy: Detection of a multiresistant cluster circulating in a heterosexual network. Clin. Microbiol. Infect. 14(10), 949-954 (2008
48. Florindo C, Pereira R, Boura M et al. Genotypes and antimicrobial- resistant phenotypes of Neisseria gonorrhoeae in Portugal (2004-2009). Sex. Transm. Infect. 86(6), 449-453 (2010
49. Wong WW, Huang CT, Li LH, Chiang CC, Chen BD, Li SY. Molecular epidemiological identification of Neisseria gonorrhoeae clonal clusters with distinct susceptibility profiles associated with specific groups at high risk of contracting human immunodeficiency virus and syphilis. J. Clin. Microbiol. 46(12), 3931-3934 (2008
50. Morris AK, Palmer HM, Young H. Opa-typing can identify epidemiologically distinct subgroups within Neisseria gonorrhoeae multi-antigen sequence type (NG-MAST) clusters. Epidemiol. Infect. 136(3), 417-420 (2008 (Pubitemid 351233858)
51. Bilek N, Martin IM, Bell G, Kinghorn GR, Ison CA, Spratt BG. Concordance between Neisseria gonorrhoeae genotypes recovered from known sexual contacts. J. Clin. Microbiol. 45(11), 3564-3567 (2007 (Pubitemid 350156849)
52. Golparian D, Hellmark B, Fredlund H, Unemo M. Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden. Sex. Transm. Infect. 86(6), 454-460 (2010
53. Palmer HM, Young H, Graham C, Dave J. Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing. Sex. Transm. Infect. 84(4), 280-284 (2008
54. Whiley DM, Goire N, Ray ES et al. Neisseria gonorrhoeae multi-antigen sequence typing using non-cultured clinical specimens. Sex. Transm. Infect. 86(1), 51-55 (2010
55. Ison C. GC NAATs: Is the time right? Sex. Transm. Infect. 82(6), 515 (2006
56. Ota KV, Tamari IE, Smieja M et al. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD Probetec ET system, the Gen-Probe Aptima Combo 2 assay and culture. Sex. Transm. Infect. 85(3), 182-186 (2009
57. Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex. Transm. Infect. 35(7), 637-642 (2008
58. Alexander S. The challenges of detecting gonorrhoea and chlamydia in rectal and pharyngeal sites: Could we, should we, be doing morê Sex. Transm. Infect. 85(3), 159-160 (2009
59. Bala M, Ray K, Gupta SM, Muralidhar S, Jain RK. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains. J. Antimicrob. Chemother. 60(3), 582-586 (2007 (Pubitemid 47299872)
60. Tapsall J, Read P, Carmody C et al. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J. Med. Microbiol. 58(5), 683-687 (2009
61. Tapsall JW. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci. Sex. Transm. Infect. 85(4), 256-258 (2009
62. Tapsall JW. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins. Curr. Opin. Infect. Dis. 22(1), 87-91 (2009
63. Chisholm SA, Alexander S, Desouza-Thomas L et al. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales. J. Antimicrob. Chemother. DOI: 10.1093/jac/dkr332 (2011) (Epub ahead of print
64. Jephcott, AE. Microbiological diagnosis of gonorrhoea. Genitourin. Med. 73(4), 245-252 (1997 (Pubitemid 27376685)
65. Bachmann LH, Desmond RA, Stephens J, Hughes A, Hook EW 3rd. Duration of persistence of gonococcal DNA detected by ligase chain reaction in men and women following recommended therapy for uncomplicated gonorrhoea. J. Clin. Microbiol. 40(10), 3596-35601 (2002
66. Chisholm SA, Mouton JW, Lewis DA, Nichols T, Ison CA, Livermore DM. Cephalosporin MIC creep among gonococci: Time for a pharmacodynamic rethink? J. Antimicrob. Chemother. 65(10), 2141-2148 (2010
67. Ohnishi M, Golparian D, Shimuta K et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhoeâDetailed characterization of the first high-level ceftriaxone resistant strain. Antimicrob. Agents Chemother. 55(7), 3538-3545 (2011). . First detailed analysis of the mechanism of high-level resistance to ceftriaxone.